Theravance Buy Hold or Sell Recommendation

    THRX -- USA Stock  

    null 9.81  9.81  9,223,372,036,855%

    Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Theravance is 'Not Rated'. Macroaxis provides Theravance buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding THRX positions. The advice algorithm takes into account all of Theravance available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from THRX buy-and-hold prospective. Also please take a look at World Market Map.

    Time Horizon

    Risk Tolerance

    Execute Advice
    Sell TheravanceBuy Theravance
    Not Rated
    For the selected time horizon Theravance has a risk adjusted performance of 0.0, jensen alpha of 0.0, total risk alpha of 0.0, sortino ratio of 0.0 and treynor ratio of 0.0
    We provide advice to complement the current expert consensus on Theravance. Our dynamic recommendation engine harnesses multi - dimensional algorithm to analyze the corporation potential to grow using all technical and fundamental data available at the time. To make sure Theravance is not overpriced, please validate all Theravance fundamentals including its Cash per Share, and the relationship between Price to Book and Number of Employees . Given that Theravance has Number of Shares Shorted of 24.88 M, we advise you double-check Theravance market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your current risk tolerance and investing horizon.

    Theravance Alerts

    Trading Alerts and Improvement Suggestions

    Theravance has high likelihood to experience some financial distress in the next 2 years
    The company reported previous year revenue of 38.39 M. Net Loss for the year was (38.99 M) with profit before overhead, payroll, taxes, and interest of 8.43 M.
    THERAVANCE currently holds about 206.19 M in cash with (1.4 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.76.
    Over 86.0% of the company shares are owned by institutional investors
    Also please take a look at World Market Map. Please also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .